Pancreatic Cancer Research

ResearcherDuke Medical CenterNo recent work listed

Herbert Kim Lyerly

ORCID-verified (high confidence)As of 10 November 2026

Matched on ORCID iD 0000-0002-0063-4770; OpenAlex author ID A5012804507.

Their work

Papers
1 (first author 0, last author 1)
Trials
2
Grants
0
Collaborators
4
Papers, trials and grants by year

1997: 1 trial · 1998: none · 1999: none · 2000: none · 2001: none · 2002: 1 trial · 2003: none · 2004: none · 2005: none · 2006: none · 2007: none · 2008: none · 2009: none · 2010: none · 2011: none · 2012: none · 2013: none · 2014: none · 2015: none · 2016: none · 2017: 1 paper

Papers 1

  1. Dendritic Cell/Cytokine-Induced Killer Cell Immunotherapy Combined with S-1 in Patients with Advanced Pancreatic Cancer: A Prospective Study. Last author DOI 10.1158/1078-0432.ccr-17-0492↗

Trials 2

  1. Vaccine Therapy in Treating Patients With Advanced or Metastatic Cancer Study chair NCT00027534↗
  2. Biological Therapy in Treating Patients With Metastatic Cancer Study chair NCT00004604↗

Closest collaborators

The 4 strongest of 4 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

  1. Guoliang Qiao · 1 shared paper, 2017
  2. Feng Chen · 1 shared paper, 2017
  3. Ni Jiang · 1 shared paper, 2017
  4. Michael Andrew Morse · 1 shared paper, 2017

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.